Search Results
May 26, 2026, 08:40 ET Lion Delivers High-Grade Copper Intercepts and Positive Metallurgy on Low-Low Grade Mineralization
Estimate (MRE) on Lion, and an update of the Nisk Ni-Cu-Pd deposit MRE with completion and reporting of estimates by the end of July. This MRE will form the basis for a Preliminary Economic Assessment (PEA) to begin immediately following the completion of the MRE.This news release also reports
More news about: Power Metallic Mines Inc.
May 26, 2026, 08:38 ET LifeKnight, Inc. Advances Four-Patent Strategy Around AI-Driven Emergency Response Architecture
structure means the architecture being protected predates the broad commercial deployment of wearable safety features now in market. Together, the patents form an interlocking thicket covering each layer of the emergency response chain: the edge device that originates the event, the AI agent that determines
More news about: LifeKnight, Inc.
May 26, 2026, 08:30 ET BOXABL Announces State-Level Approval in Texas, the Largest Emerging Housing Market in the U.S., Accelerating Growth Ahead of the Proposed FGMC Merger
has been filed by FGMC in a Current Report on Form 8-K with the U.S. Securities and Exchange Commission (the "SEC"). The proposed transaction has been submitted to shareholders of FGMC for their consideration. FGMC has filed a registration statement on Form S-4 (the "Registration Statement") with the SEC,
More news about: Boxabl
May 26, 2026, 08:30 ET Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.Perrigo ContactEric Jacobson, Vice President, Global Investor Relations(616)
More news about: Perrigo Company plc
May 26, 2026, 08:30 ET Alexandria Real Estate Equities, Inc. Celebrates Consequential Impact Achieved Through its Longstanding Partnership with the Navy SEAL Foundation
please refer to Alexandria's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and any subsequently filed quarterly reports on Form 10-Q.CONTACT: Sara Cohen, Assistant Vice President – Corporate Strategy Events, (646) 799-2617,
More news about: Alexandria Real Estate Equities, Inc.
May 26, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.39 Million Tokens, and Total Crypto and Total Cash Holdings of $12.3 Billion
statements are subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings
More news about: Bitmine Immersion Technologies, Inc.
May 26, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.39 Million Tokens, and Total Crypto and Total Cash Holdings of $12.3 Billion
statements are subject to numerous conditions, many of which are beyond Bitmine's control, including those set forth in the Risk Factors section of Bitmine's Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine's filings
More news about: Bitmine Immersion Technologies, Inc.
May 26, 2026, 08:30 ET Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
key personnel as well as risks, uncertainties, and other factors described in the section titled "Risk Factors" and elsewhere in our Annual Report on Form 10-K filed on or about March 3, 2026, and in our other filings we make with the SEC from time to time. We undertake no obligation to update any forward-looking
More news about: Caris Life Sciences
May 26, 2026, 08:28 ET TopGum Continues Its Rapid Growth Trend and Opens 2026 with Another Record Quarter
in its field.About TopGumFounded in 2004, TopGum is a global leader in the manufacturing of dietary supplements in gummy dosage form, with products sold worldwide. The Group's manufacturing facilities are located in Israel, Canada, and the US. TopGum employs more than 400 people and
More news about: TopGum Industries Ltd.
May 26, 2026, 08:18 ET Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform
various important factors, including, without limitation, market conditions and the factors described in the section titled "Risk Factors" in Hoth's most recent Annual Report on Form 10-K and Hoth's other filings made with the U. S. Securities and Exchange Commission. All such statements speak only as of the date made. Consequently,
More news about: Hoth Therapeutics, Inc.
May 26, 2026, 08:15 ET Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
disclosures made by the Company in its reports filed with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as revised or supplemented by its Quarterly Reports on Form 10-Q and other documents filed with the SEC. If one or more of these risks or uncertainties materialize,
More news about: Decoy Therapeutics, Inc
May 26, 2026, 08:05 ET Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.Investor Contact:Steven M. HarasymTel:
More news about: Precigen, Inc.
May 26, 2026, 08:01 ET Culligan Purity™ Wins 2026 Red Dot Award for Innovative Commercial Water Filtration Design
innovation with elevated design and proactive service technologies operating in unison to remove friction from the user experience. Its clean, contemporary form and intuitive interface make hydration effortless, while its modular architecture and IoT-enabled diagnostics allow Culligan service teams to proactively
More news about: Culligan
May 26, 2026, 08:00 ET Northwest Bank Names Chad Ballard as Chief Information Officer
cause actual results to differ materially from those contemplated by such forward-looking statements are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 under the section entitled "Item 1A - Risk Factors," and from time to time in other filings made by the Company
More news about: Northwest Bank
May 26, 2026, 08:00 ET World Surf League Partners with SURF as the Official Dating App of the Lexus US Open of Surfing Presented by Pacifico
[email protected] SURFFounded in 2024, SURF is designed to help singles form real connections faster by bringing shared communities and real-world experiences to the forefront of modern dating. Built around a transparent, grid-style
More news about: Surf Dating
May 26, 2026, 08:00 ET Crystalys Therapeutics Doses First Patients in New Phase 2 Trial of Dotinurad for Difficult-to-Treat Gout
12-week active treatment period where all participants will take dotinurad (Treatment Period 2).About Gout Gout is the most common form of inflammatory arthritis. It is a condition that is very debilitating for patients and characterized by sudden, severe attacks of pain, swelling, redness
More news about: Crystalys Therapeutics
May 26, 2026, 08:00 ET Trinity Capital Inc. Acquires Equipment Leasing Services, Adding a New Income Generating Business to Its Platform
"Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed annual report on Form 10-K and subsequent SEC filings.About Trinity Capital Inc. Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative
More news about: Trinity Capital Inc.
May 26, 2026, 08:00 ET Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient
More news about: Genprex, Inc.
May 26, 2026, 08:00 ET CLEAR Partners with Samsung, Bringing CLEAR ID to Samsung Wallet
described in the Company's filings within the Securities and Exchange Commission, including the sections titled "Risk Factors" in our Annual Report on Form 10- K. The Company disclaims any obligation to update any forward-looking statements contained herein.CLEAR
More news about: CLEAR
May 26, 2026, 08:00 ET Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
www.sec.gov, including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2025, filed with the SEC on December 23, 2025. These forward-looking statements speak only as of the date hereof,
More news about: Citius Oncology, Inc.
May 26, 2026, 07:50 ET G. WILLI-FOOD INTERNATIONAL REPORTS THE RESULTS OF FIRST QUARTER 2026
matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission on March 24, 2026. These factors are updated from time
More news about: G. Willi-Food International Ltd.
May 26, 2026, 07:45 ET Curaleaf Announces 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting
information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on February 26, 2026, which is available under the Company's SEDAR profile at
More news about: Curaleaf Holdings, Inc.
May 26, 2026, 07:32 ET Applied Aerospace & Defense, Inc. Announces Launch of Initial Public Offering
stock, par value $0.01 per share, at an anticipated initial offering price between $18.00 and $21.00 per share pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the "SEC"). In addition, Applied intends to grant the underwriters a 30-day option to purchase
More news about: Applied Aerospace & Defense
May 26, 2026, 07:30 ET Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
the forward-looking statements. These and other important factors are described in detail in the "Risk Factors" section of Virax's Annual Report on Form 20-F for the year ended March 31, 2025. Although we believe the expectations reflected in such forward-looking statements are reasonable, we can give
More news about: Virax BioLabs Group Limited
May 26, 2026, 07:30 ET Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer
applicable NASDAQ continued listing requirements and standards. These and other risks and uncertainties are described more fully in Kazia's Annual Report on Form 20-F filed with the SEC, and in subsequent filings with the United States Securities and Exchange Commission. Kazia undertakes no obligation to publicly
More news about: Kazia Therapeutics Limited